<DOC>
	<DOCNO>NCT01979874</DOCNO>
	<brief_summary>Investigators hypothesize high-dose n-3 polyunsaturated fatty acid ( PUFA ) oral supplementation improve systemic inflammation , vascular function , symptomatic status patient PAD . Investigators explore novel mechanistic pathway n-3 PUFA affect PAD , evaluate role specialize lipid mediator involve resolution inflammation .</brief_summary>
	<brief_title>The Effects Omega-3 Fatty Acids Peripheral Arterial Disease II</brief_title>
	<detailed_description>The OMEGA-PAD II trial 1:1 randomize , double-blinded trial compare oral supplementation n-3 PUFA ( 4.4g/day ) placebo claudicants ( Rutherford stage 1-3 ) 3 month . Eligible patient screen accord specify inclusion exclusion criterion . All patient treat per current practice reflect American Heart Association Practice guideline PAD . Blood draw , vascular function test 6-minute walking test perform baseline 3 month . n-3 PUFA supplementation achieve 4 capsule Pro-Omega twice daily ( Nordic Naturals , Watsonville , California , USA ) , correspond total 4.4g/day . Each ProOmega capsule contain 325mg EPA 225mg DHA . The placebo group take number capsule contain inactive substance ( soybean ; Nordic Naturals ) , design color shape treatment capsule .</detailed_description>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<criteria>1 . Intermittent claudication ( Rutherford 13 ) 2 . One following : 1 . Resting exercise anklebrachial index ( ABI ) &lt; 0.9 2. toe pressure &lt; 70 mm Hg 3. documentation image great equal 50 % stenosis segment aortoiliac artery , femoral artery , tibial artery 3 . Age 50 1 . Critical limb ischemia 2 . Hypersensitivity/allergies fish seafood 3 . Already n3 PUFA equivalent 4 . Significant renal , hepatic , inflammatory disease 5 . Concurrent severe infection 6 . Acute illness ( myocardial infarction , stroke , major surgery within 30 day ) 7 . Receiving immunosuppressive medication steroid 8 . Age &lt; 50</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>